Literature DB >> 10494451

HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses.

J Lappalainen1, J C Long, M Virkkunen, N Ozaki, D Goldman, M Linnoila.   

Abstract

BACKGROUND: Heritable variation in brain monoaminergic activity has been suggested to lead to interindividual differences in vulnerability to alcoholism, and many other behavioral disorders. We evaluated if a functional Cys23Ser polymorphism in the 5-HT2C receptor gene, the principal serotonin receptor in the brain, contributes to variation in serotonin, norepinephrine and dopamine activity, as indexed by their major metabolite concentrations in cerebrospinal fluid (CSF). Genotype-monoamine metabolite concentration associations were subsequently correlated to risk for alcoholism.
METHODS: The study sample consisted of unrelated Finnish males, including 214 alcoholic, violent offenders and 222 population controls who were interviewed using the Structured Clinical Interview for DSM-III-R, blind rated for psychiatric diagnoses and typed for the HTR2C Cys23Ser polymorphism. CSF concentrations of 5-hydroxyindoleacetic acid (5-HIAA), the major metabolite of serotonin, 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), the major metabolite of norepinephrine, and homovanillic acid (HVA), the major metabolite of dopamine were available from 195 individuals.
RESULTS: The major finding in this study was that HTR2C CysSer23 significantly contributed to CSF MHPG concentrations (p = .012). Higher concentrations of CSF MHPG were observed both in alcoholic violent offenders and population controls with HTR2C Ser23 genotype. Despite the association of Cys23Ser to CSF MHPG, HTR2C genotype was not associated with alcoholism, nor with other psychiatric disorders present in this sample.
CONCLUSIONS: We conclude that a functional HTR2C Cys23Ser polymorphism contributes to the interindividual genetic variation of CSF MHPG explaining 3% of the total variance. This finding suggests that 5-HT2C receptors are involved in the regulation of norepinephrine turnover in humans; however, HTR2C Cys23Ser does not appear to contribute to the risk of alcoholism, or its contribution to this complex and heterogenous disorder is too small to be detected by a sample of this size and structure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10494451     DOI: 10.1016/s0006-3223(98)00361-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  16 in total

1.  5HT-2C receptor polymorphism in suicide victims. Association studies in German and Slavic populations.

Authors:  Jasminka Stefulj; Andreas Büttner; Milovan Kubat; Peter Zill; Melita Balija; Wolfgang Eisenmenger; Brigitta Bondy; Branimir Jernej
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-08       Impact factor: 5.270

Review 2.  Revisiting the serotonin-aggression relation in humans: a meta-analysis.

Authors:  Aaron A Duke; Laurent Bègue; Rob Bell; Tory Eisenlohr-Moul
Journal:  Psychol Bull       Date:  2013-02-04       Impact factor: 17.737

3.  Sertraline for the treatment of depression in Alzheimer disease: genetic influences.

Authors:  Matthew E Peters; Vijay Vaidya; Lea T Drye; Paul B Rosenberg; Barbara K Martin; Anton P Porsteinsson; Constantine E Frangakis; Jacobo Mintzer; Daniel Weintraub; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos; Dimitri Avramopoulos; Avramopoulos Dimitri
Journal:  J Geriatr Psychiatry Neurol       Date:  2011-12       Impact factor: 2.680

4.  Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients.

Authors:  Arzu Gunes; Marja-Liisa Dahl; Edoardo Spina; Maria Gabriella Scordo
Journal:  Eur J Clin Pharmacol       Date:  2008-01-18       Impact factor: 2.953

5.  Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.

Authors:  Matthew E Peters; Vijay Vaidya; Lea T Drye; Davangere P Devanand; Jacobo E Mintzer; Bruce G Pollock; Anton P Porsteinsson; Paul B Rosenberg; Lon S Schneider; David M Shade; Daniel Weintraub; Jerome Yesavage; Constantine G Lyketsos; Dimitri Avramopoulos
Journal:  J Geriatr Psychiatry Neurol       Date:  2015-08-23       Impact factor: 2.680

Review 6.  Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease.

Authors:  Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2008-03-26       Impact factor: 8.989

7.  A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior.

Authors:  Rickard L Sjöberg; Francesca Ducci; Christina S Barr; Timothy K Newman; Liliana Dell'osso; Matti Virkkunen; David Goldman
Journal:  Neuropsychopharmacology       Date:  2007-04-11       Impact factor: 7.853

8.  Complex HTR2C linkage disequilibrium and promoter associations with body mass index and serum leptin.

Authors:  Shane McCarthy; Salim Mottagui-Tabar; Yumi Mizuno; Bengt Sennblad; Johan Hoffstedt; Peter Arner; Claes Wahlestedt; Björn Andersson
Journal:  Hum Genet       Date:  2005-07-14       Impact factor: 4.132

9.  Polymorphisms of the serotonin transporter and receptor genes: susceptibility to substance abuse.

Authors:  Aryeh I Herman; Kornelia N Balogh
Journal:  Subst Abuse Rehabil       Date:  2012-06

10.  Genetic association study and meta-analysis of the HTR2C Cys23Ser polymorphism and migraine.

Authors:  Agustin Oterino; Jesus Castillo; Julio Pascual; Amalia Cayon; Ana Alonso; Carlos Ruiz-Alegria; Natalia Valle; Fernando Monton; Nuria Ruiz-Lavilla
Journal:  J Headache Pain       Date:  2007-09-24       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.